October 31, 2013-The Economic Times: Patent office rejects BDR Pharma's compulsory licensing applicationAugust 6, 2013: Kractivism: Press Release- Campaign for Affordable Trastuzumab (links to kractivist.org) August 5, 2013 - Bio World: China Revokes Viread Patent; Pricing Was at Issue (links to bioworld.com)
May 30, 2013- The Jakarta Globe: Future Hepatitis C Blockbusters May Spawn Compulsory Generics (links to thejakartaglobe.com)March 18, 2013- ACTION! Essential Inventions issues request for non-voluntary authorization to use patents under Article 14 of Greece patent law (links to essentialinventions.org)
March 17, 2013-Financial Times: Athens urged to import generic drugs (links to ft.com)December, 2012- Secondary Patenting: A Threat to Affordable Generic Patenting by I-MAK
November 2, 2012- Nature: NIH asked to grant open license on HIV drug (links to blogs.nature.com)
October 25, 2012-ACTION! Knowledge Ecology International: Four NGOs ask NIH to grant open licenses to ritonavir patents under Bayh-Dole March-in provisions (links to keionline.org)
October 22, 2012-The Star (Malaysia): Measure to make drugs affordable (links to thestar.com.my)
October 12, 2012-Reuters: Indonesia acts to over-ride patents on HIV drugs (links to uk.reuters.com)
October 11, 2012-ACTION! The Guardian: Indonesia in bold move to obtain cheap drugs for HIV (links to guardian.co.uk)
Link to Indonesia action page
For more information, contact us at email@example.com
Return to the Kaletra Campaign Homepage
Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.
You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.
Public Citizen lobbies Congress
and federal agencies to advance Public Citizen’s mission of advancing
government and corporate accountability. When you make a contribution to Public
Citizen, you become a member of Public Citizen, showing your support and entitling
you to benefits such as Public Citizen
News. Contributions to Public Citizen are not tax-deductible.
Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.